Clinical Trial Update: Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 study update evaluating IMC-A12 (cixutumumab) in combination with hormone therapy before surgery for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• IMC-A12 (cixutumumab)

Snippet

Sponsor: University of Washington | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED